102 related articles for article (PubMed ID: 26781175)
1. TLR4‑dependent signaling pathway modulation: A novel mechanism by which pioglitazone protects against nutritional fibrotic steatohepatitis in mice.
Du J; Niu X; Wang R; Zhao S; Kong L; Zhang Y; Nan Y
Mol Med Rep; 2016 Mar; 13(3):2159-66. PubMed ID: 26781175
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated peroxisome proliferator activated receptor gamma overexpression prevents nutritional fibrotic steatohepatitis in mice.
Nan YM; Han F; Kong LB; Zhao SX; Wang RQ; Wu WJ; Yu J
Scand J Gastroenterol; 2011 Mar; 46(3):358-69. PubMed ID: 20969493
[TBL] [Abstract][Full Text] [Related]
3. [Peroxisome proliferator activated receptor gamma activation and overexpression prevent hepatocellular apoptosis of nutritional fibrotic steatohepatitis in mice].
Nan YM; Han F; Kong LB; Li Y; Wang RQ; Zhao SX
Zhonghua Gan Zang Bing Za Zhi; 2011 Jul; 19(7):521-6. PubMed ID: 22152244
[TBL] [Abstract][Full Text] [Related]
4. The Ethanol Extract from Lonicera japonica Thunb. Regresses Nonalcoholic Steatohepatitis in a Methionine- and Choline-Deficient Diet-Fed Animal Model.
Tzeng TF; Tzeng YC; Cheng YJ; Liou SS; Liu IM
Nutrients; 2015 Oct; 7(10):8670-84. PubMed ID: 26506376
[TBL] [Abstract][Full Text] [Related]
5. Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice.
Tomita K; Teratani T; Suzuki T; Shimizu M; Sato H; Narimatsu K; Okada Y; Kurihara C; Irie R; Yokoyama H; Shimamura K; Usui S; Ebinuma H; Saito H; Watanabe C; Komoto S; Kawaguchi A; Nagao S; Sugiyama K; Hokari R; Kanai T; Miura S; Hibi T
Hepatology; 2014 Jan; 59(1):154-69. PubMed ID: 23832448
[TBL] [Abstract][Full Text] [Related]
6. Interferon-β Mediates Signaling Pathways Uniquely Regulated in Hepatic Stellate Cells and Attenuates the Progression of Hepatic Fibrosis in a Dietary Mouse Model.
Shimozono R; Nishimura K; Akiyama H; Funamoto S; Izawa A; Sai T; Kunita K; Kainoh M; Suzuki T; Kawada N
J Interferon Cytokine Res; 2015 Jun; 35(6):464-73. PubMed ID: 25715168
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice.
Nan YM; Fu N; Wu WJ; Liang BL; Wang RQ; Zhao SX; Zhao JM; Yu J
Scand J Gastroenterol; 2009; 44(3):358-65. PubMed ID: 18991162
[TBL] [Abstract][Full Text] [Related]
8. Induction of heme oxygenase-1 protects against nutritional fibrosing steatohepatitis in mice.
Wang RQ; Nan YM; Wu WJ; Kong LB; Han F; Zhao SX; Kong L; Yu J
Lipids Health Dis; 2011 Feb; 10():31. PubMed ID: 21314960
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone attenuates hepatic inflammation and fibrosis in phosphatidylethanolamine N-methyltransferase-deficient mice.
van der Veen JN; Lingrell S; Gao X; Quiroga AD; Takawale A; Armstrong EA; Yager JY; Kassiri Z; Lehner R; Vance DE; Jacobs RL
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G526-38. PubMed ID: 26797396
[TBL] [Abstract][Full Text] [Related]
10. Dietary Supplementation of Genistein Alleviates Liver Inflammation and Fibrosis Mediated by a Methionine-Choline-Deficient Diet in db/db Mice.
Yoo NY; Jeon S; Nam Y; Park YJ; Won SB; Kwon YH
J Agric Food Chem; 2015 May; 63(17):4305-11. PubMed ID: 25885479
[TBL] [Abstract][Full Text] [Related]
11. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway.
Shi H; Dong L; Jiang J; Zhao J; Zhao G; Dang X; Lu X; Jia M
Toxicology; 2013 Jan; 303():107-14. PubMed ID: 23146752
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
13. Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis.
Marcolin E; San-Miguel B; Vallejo D; Tieppo J; Marroni N; González-Gallego J; Tuñón MJ
J Nutr; 2012 Oct; 142(10):1821-8. PubMed ID: 22915297
[TBL] [Abstract][Full Text] [Related]
14. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro.
Yu J; Zhang S; Chu ES; Go MY; Lau RH; Zhao J; Wu CW; Tong L; Zhao J; Poon TC; Sung JJ
Int J Biochem Cell Biol; 2010 Jun; 42(6):948-57. PubMed ID: 20156580
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
[TBL] [Abstract][Full Text] [Related]
17. Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice.
Nan YM; Wu WJ; Fu N; Liang BL; Wang RQ; Li LX; Zhao SX; Zhao JM; Yu J
Scand J Gastroenterol; 2009; 44(9):1121-31. PubMed ID: 19606393
[TBL] [Abstract][Full Text] [Related]
18. IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet.
Luo XY; Takahara T; Kawai K; Fujino M; Sugiyama T; Tsuneyama K; Tsukada K; Nakae S; Zhong L; Li XK
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(12):G891-9. PubMed ID: 24136786
[TBL] [Abstract][Full Text] [Related]
19. Fuzheng Huayu recipe prevents nutritional fibrosing steatohepatitis in mice.
Jia YH; Wang RQ; Mi HM; Kong LB; Ren WG; Li WC; Zhao SX; Zhang YG; Wu WJ; Nan YM; Yu J
Lipids Health Dis; 2012 Mar; 11():45. PubMed ID: 22452814
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway.
Zhang W; Wu R; Zhang F; Xu Y; Liu B; Yang Y; Zhou H; Wang L; Wan K; Xiao X; Zhang X
Clin Exp Pharmacol Physiol; 2012 Dec; 39(12):1026-33. PubMed ID: 23127227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
